2 dividend stocks I’d hold for the next 20 years

Could these two dividend shares make you a mint? Royston Wild thinks so.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

dividend scrabble piece spelling

With housebuilding demand on course to keep rising in the years ahead, I am backing Forterra (LSE: FORT) to generate exceptional profits growth for many moons to come.

Build rates in the UK have been lagging requirements for decades now, and politicians are only really beginning to cotton on to the scale of the problem as ‘Generation Rent’ swells in numbers. The Conservative government has vowed to take fresh measures to remedy the housing shortfall and it will need to maintain this commitment as it battles against falling voter numbers. And this bodes well for sellers of building materials like Forterra.

Indeed, the country’s second biggest provider of bricks, plans to fully utilise this favourable backdrop by dealing with bottlenecks at its facilities, while it is also drawing up plans to construct a jumbo new brick manufacturing facility.

The Northamptonshire business is already enjoying strong demand for its heavy construction products as housebuilder activity chugs steadily higher. It saw revenues rise 12.4% — or 10.4%, excluding the acquisition of precast concrete specialist Bison last year — to £331m. It said that this bubbly result was “due to strong demand in the new-build residential market leading to [a] double-digit increase in brick and aggregate block volumes.”

And critically, while Forterra is battling against a rising cost base, the positive market fundamentals are allowing it to successfully pass these larger expenses onto its customers.

Brick beauty

Against this backcloth City analysts are expecting the small-cap to deliver solid earnings growth of 8% in both 2018 and 2019. This, combined with the Forterra’s surging cash flows — operating cash flow jumped to £90.2m last year from £69.8m in 2016 — is expected to keep dividends swelling at a splendid pace too.

Last year’s 9.5p per share reward is anticipated to rise to 10.5p in the current period and again to 11.5p in 2019. Consequently investors can drink in chunky yields of 3.4% and 3.7% for this year and next respectively.

Despite its bright profits picture, Forterra deals on a forward P/E ratio of just 11.8 times. This makes it an irresistible pick right now, in my opinion.

Marketing star

Communisis (LSE: CMS) is another dirt-cheap small-cap on course to put out meaty dividends in the near term and beyond.

An anticipated 6% earnings improvement in 2018 leaves the company trading on a prospective P/E multiple of just 9.1 times. This bright bottom-line outlook also gives rise to predictions of further dividend growth with a predicted 2.9p per share reward, which is up from the 2.66p paid out last year and carrying a stunning 4.7%.

The good news spills over into next year as well, with an anticipated 7% profits rise giving rise to an estimated 3p payment. This means the yield leaps to a chubby 4.8%.

Communisis is an important marketing partner with major companies all over the world, and its ability to keep grinding out long-running contracts with such businesses convinces me that it should remain a lucrative stock for years to come.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »